Polyomavirus infections occur commonly in humans and are normally nonfatal. However, in immunocompromised individuals, they are intractable and frequently fatal. Due to a lack of approved drugs to treat polyomavirus infections, cidofovir, a phosphonate nucleotide analog approved to treat cytomegalovirus infections, has been repurposed as an antipolyomavirus agent. Cidofovir has been modified in various ways to improve its efficacies as a broad-spectrum antiviral agent. However, the actual mechanisms and targets of cidofovir and its modified derivatives as antipolyomavirus agents are still under research. Here, polyomavirus large tumor antigen (Tag) activities were identified as the viral target of cidofovir derivatives. The alkoxyalkyl ester derivatives of cidofovir efficiently inhibit polyomavirus DNA replication in cell-free human extracts and a viral in vitro replication system utilizing only purified proteins. We present evidence that DNA helicase and DNA binding activities of polyomavirus Tags are diminished in the presence of low concentrations of alkoxyalkyl ester derivatives of cidofovir, suggesting that the inhibition of viral DNA replication is at least in part mediated by inhibiting single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA) binding activities of Tags. These findings show that the alkoxyalkyl ester derivatives of cidofovir are effective in vitro without undergoing further conversions, and we conclude that the inhibitory mechanisms of nucleotide analog-based drugs are more complex than previously believed.

Biochemistry School of Natural Science and Centre for Chromosome Biology NUI Galway Galway Ireland

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences Prague Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc21019222

003      

CZ-PrNML

005      

20210830100805.0

007      

ta

008      

210728s2021 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.1128/AAC.01641-20 $2 doi

035    __

$a (PubMed)33288638

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Onwubiko, Nichodemus O $u Biochemistry, School of Natural Science and Centre for Chromosome Biology, NUI Galway, Galway, Ireland

245    10

$a Alkoxylalkyl Esters of Nucleotide Analogs Inhibit Polyomavirus DNA Replication and Large T Antigen Activities / $c NO. Onwubiko, SA. Diaz, M. Krečmerová, HP. Nasheuer

520    9_

$a Polyomavirus infections occur commonly in humans and are normally nonfatal. However, in immunocompromised individuals, they are intractable and frequently fatal. Due to a lack of approved drugs to treat polyomavirus infections, cidofovir, a phosphonate nucleotide analog approved to treat cytomegalovirus infections, has been repurposed as an antipolyomavirus agent. Cidofovir has been modified in various ways to improve its efficacies as a broad-spectrum antiviral agent. However, the actual mechanisms and targets of cidofovir and its modified derivatives as antipolyomavirus agents are still under research. Here, polyomavirus large tumor antigen (Tag) activities were identified as the viral target of cidofovir derivatives. The alkoxyalkyl ester derivatives of cidofovir efficiently inhibit polyomavirus DNA replication in cell-free human extracts and a viral in vitro replication system utilizing only purified proteins. We present evidence that DNA helicase and DNA binding activities of polyomavirus Tags are diminished in the presence of low concentrations of alkoxyalkyl ester derivatives of cidofovir, suggesting that the inhibition of viral DNA replication is at least in part mediated by inhibiting single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA) binding activities of Tags. These findings show that the alkoxyalkyl ester derivatives of cidofovir are effective in vitro without undergoing further conversions, and we conclude that the inhibitory mechanisms of nucleotide analog-based drugs are more complex than previously believed.

650    12

$a antigeny virové nádorové $7 D000957

650    _2

$a cytosin $7 D003596

650    _2

$a replikace DNA $7 D004261

650    _2

$a DNA virů $x genetika $7 D004279

650    _2

$a estery $x farmakologie $7 D004952

650    _2

$a lidé $7 D006801

650    _2

$a nukleotidy $7 D009711

650    12

$a Polyomavirus $x genetika $7 D011120

650    _2

$a replikace viru $7 D014779

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Diaz, Suraya A $u Biochemistry, School of Natural Science and Centre for Chromosome Biology, NUI Galway, Galway, Ireland

700    1_

$a Krečmerová, Marcela $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic

700    1_

$a Nasheuer, Heinz Peter $u Biochemistry, School of Natural Science and Centre for Chromosome Biology, NUI Galway, Galway, Ireland heinz.nasheuer@nuigalway.ie

773    0_

$w MED00009215 $t Antimicrobial agents and chemotherapy $x 1098-6596 $g Roč. 65, č. 3 (2021)

856    41

$u https://pubmed.ncbi.nlm.nih.gov/33288638 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y p $z 0

990    __

$a 20210728 $b ABA008

991    __

$a 20210830100805 $b ABA008

999    __

$a ok $b bmc $g 1690119 $s 1139668

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2021 $b 65 $c 3 $e 20210217 $i 1098-6596 $m Antimicrobial agents and chemotherapy $n Antimicrob Agents Chemother $x MED00009215

LZP    __

$a Pubmed-20210728